National Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb leaves the agency next month.
National Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb leaves the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.
"It will be an honor to advance the FDA's critical public health mission and build on its progress toward the priorities laid out by President Trump, Secretary Azar, and Commissioner Gottlieb alongside the leadership and staff of the agency," Sharpless said in a statement. Gottlieb's resignation took Washington and the health-care community by surprise. Some wondered what would happen to some of the initiatives he led, such as a crackdown on teen vaping. Shares of Marlboro cigarette maker Altria retreated after Azar announced Sharpless' appointment.
In an email to FDA staff, Gottlieb said Sharpless is a"valued colleague to the FDA and is deeply committed to public health."
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
National Cancer Institute Director Ned Sharpless will be acting FDA commissionerNational Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb steps down from the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.
Read more »
Altria shares hit after National Cancer Institute director named acting head of the FDAAltria investors don't seem to like the prospects for the cigarette maker under the new acting FDA commissioner.
Read more »
Trump proposal would slash total cancer funding while boosting pediatric cancer researchThe administration proposed a $50 million increase in funding for pediatric cancer research. But the budget also included a large overall cut for the National Cancer Institute, upsetting researchers.
Read more »
'Jeopardy' Host Alex Trebek Revealed He Has Stage 4 Pancreatic Cancer'I plan to beat the low survival rate statistics for this disease,' Trebek said, asking fans for their prayers.
Read more »
FDA approves first immunotherapy regimen for breast cancerThe US Food and Drug Administration granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. The drug, Genentech's Tecentriq, was approved for use in combination with Abraxane chemotherapy for patients who have a type of advanced triple negative breast cancer.
Read more »
Roche's Tecentriq notches win in breast cancer with U.S. approvalRoche won U.S. approval on Friday of its immunotherapy Tecentriq to treat a sign...
Read more »
Often diagnosed too late, hope for pancreatic cancer may be on the horizonEfforts to improve early detection and more targeted treatment approaches could offer some hope, experts say.
Read more »
The African Childhood Cancer Specialists Lost On Ethiopian Airlines Flight 302Among the 32 Kenyans onboard Ethiopian Airlines flight 302 were three women on their way back home after a conference focused on improving the lives of children with cancer in Africa.
Read more »
Police searched a cancer patient’s room for marijuana after someone called 911Nolan Sousley, who says he has Stage 4 pancreatic cancer, said police searched his 'final-day' bag for marijuana at Citizens Memorial Hospital in Bolivar, Mo.
Read more »